CARBAGLU (carglumic acid) tablets

Carbaglu is used to treat hyperammonemia (HYE-per-AM-moe-NEE-mee-a), a urea cycle disorder caused by lack of a certain liver enzyme. Carbaglu is usually given with other medications to treat this lifelong disorder. Brand Name: CARBAGLU (carglumic acid) tablets Initial U.S. Approval: 2010

Home | Carglumic acid tablets

CARBAGLU (carglumic acid) tablets price in India and Overseas
CARBAGLU (carglumic acid) tablets

Submit a request to access drug used to treat, diagnose or prevent serious or life-threatening conditions.We’ll get back to you within 1 business days!

CARBAGLU (carglumic acid) tablets

Carglumic acid is used for the treatment of hyperammonaemia. Carglumic acid is a carbamoyl phosphate synthetase 1 (CPS 1) activator.

For Indian Patient Enquiry under NPP.

For any urgent inquiries or assistance needed, please reach out to our Support Team. Rest assured, we will respond within 24 hours, from Monday to Saturday, during the hours of 9:00 A.M to 18:00 PM.

Carbaglu (carglumic acid) is a Carbamoyl Phosphate Synthetase 1 (CPS 1) activator indicated as:
• Adjunctive therapy for the treatment of acute hyperammonemia due to the deficiency of the hepatic enzyme N-acetylglutamate synthase (NAGS).
• Maintenance therapy for the treatment of chronic hyperammonemia due to the deficiency of the hepatic enzyme N-acetylglutamate synthase (NAGS).

Carglumic acid is indicated for the treatment of acute hyperammonemia and chronic hyperammonemia. Carglumic acid, sold under the brand name Carbaglu among others, is used for the treatment of hyperammonaemia. It was approved for medical use in the United States in March 2010.[7] Carglumic acid is an orphan drug.

Drug (Brand / Generic): CARBAGLU / carglumic acid
Current Indications: acute hyperammonemia and chronic hyperammonemia
Marketed by::Orphan Europe
Approval Date: 2010

Dosage forms and strengths of CARBAGLU (carglumic acid).
200 mg tablets, scored.

For more highlights of prescribing information regarding Indications and usage, dosage and administration, dosage forms and strengths, patient counseling information and medication guide. Click Here

Alleviare Life Sciences

About Us

Alleviare Life Sciences Pvt. Ltd. (India) serves as a facilitator for medical and pharmaceutical products, commencing its operations in 2005. Headquartered in Delhi, India, Alleviare operates nationwide, providing a range of comprehensive services to patients, doctors, hospitals, and government healthcare facilities.

Our specialization lies in facilitating access to medicines, leveraging our expertise in sourcing and providing documentation assistance for programs such as Named Patient Program, Managed Access Program, and Early Access Program. We take pride in ensuring smooth and efficient access to medications for those who require them.

Alleviare India, a certified pharmaceutical facilitator / supplier / importer of specialty medicines or drugs based in India.